Ribaldone, D G <br/><br/>
Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  01 2018 
 - 146-147 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.14321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biological Products<br/>Crohn Disease<br/>Digestive System Surgical Procedures<br/>Humans<br/>Infliximab<br/>Tumor Necrosis Factor-alpha